A citation-based method for searching scientific literature

Geoff Macintyre, Teodora E Goranova, Dilrini De Silva, Darren Ennis, Anna M Piskorz, Matthew Eldridge, Daoud Sie, Liz-Anne Lewsley, Aishah Hanif, Cheryl Wilson, Suzanne Dowson, Rosalind M Glasspool, Michelle Lockley, Elly Brockbank, Ana Montes, Axel Walther, Sudha Sundar, Richard Edmondson, Geoff D Hall, Andrew Clamp, Charlie Gourley, Marcia Hall, Christina Fotopoulou, Hani Gabra, James Paul, Anna Supernat, David Millan, Aoisha Hoyle, Gareth Bryson, Craig Nourse, Laura Mincarelli, Luis Navarro Sanchez, Bauke Ylstra, Mercedes Jimenez-Linan, Luiza Moore, Oliver Hofmann, Florian Markowetz, Iain A McNeish, James D Brenton. Nat Genet 2018
Times Cited: 112



Silvia Domcke, Rileen Sinha, Douglas A Levine, Chris Sander, Nikolaus Schultz. Nat Commun 2013
Times Cited: 745




List of shared articles



Times cited

Genetically Defined, Syngeneic Organoid Platform for Developing Combination Therapies for Ovarian Cancer.
Shuang Zhang, Sonia Iyer, Hao Ran, Igor Dolgalev, Shengqing Gu, Wei Wei, Connor J R Foster, Cynthia A Loomis, Narciso Olvera, Fanny Dao,[...]. Cancer Discov 2021
8

Joint IARC/NCI International Cancer Seminar Series Report: expert consensus on future directions for ovarian carcinoma research.
Shama Virani, Glauco Baiocchi, David Bowtell, Citadel J Cabasag, Kathleen R Cho, Renée T Fortner, Keiichi Fujiwara, Jae-Weon Kim, Martin Köbel, Jean-Emmanuel Kurtz,[...]. Carcinogenesis 2021
0

Inhibition of the mTOR pathway and reprogramming of protein synthesis by MDM4 reduce ovarian cancer metastatic properties.
Rossella Lucà, Maria Rita Assenza, Fabio Maiullari, Luisa Pieroni, Silvia Maiullari, Giulia Federici, Federica Marini, Roberto Rizzi, Andrea Urbani, Silvia Soddu,[...]. Cell Death Dis 2021
0


A living biobank of ovarian cancer ex vivo models reveals profound mitotic heterogeneity.
Louisa Nelson, Anthony Tighe, Anya Golder, Samantha Littler, Bjorn Bakker, Daniela Moralli, Syed Murtuza Baker, Ian J Donaldson, Diana C J Spierings, René Wardenaar,[...]. Nat Commun 2020
23

Identification of ovarian high-grade serous carcinoma cell lines that show estrogen-sensitive growth as xenografts in immunocompromised mice.
Alexis De Haven Brandon, Gary Box, Albert Hallsworth, William Court, Nicoll Matthews, Balint Herodek, Aitor Bermejo Arteagabeitia, Melanie Valenti, Vladimir Kirkin. Sci Rep 2020
5

Specific Mechanisms of Chromosomal Instability Indicate Therapeutic Sensitivities in High-Grade Serous Ovarian Carcinoma.
Naoka Tamura, Nadeem Shaikh, Daniel Muliaditan, Tanya N Soliman, Jennifer R McGuinness, Eleni Maniati, Daniela Moralli, Mary-Anne Durin, Catherine M Green, Frances R Balkwill,[...]. Cancer Res 2020
7

High-throughput approaches for precision medicine in high-grade serous ovarian cancer.
Meinusha Govindarajan, Christoph Wohlmuth, Matthew Waas, Marcus Q Bernardini, Thomas Kislinger. J Hematol Oncol 2020
6

Combined MEK and BCL-2/XL Inhibition Is Effective in High-Grade Serous Ovarian Cancer Patient-Derived Xenograft Models and BIM Levels Are Predictive of Responsiveness.
Claudia Iavarone, Ioannis K Zervantonakis, Laura M Selfors, Sangeetha Palakurthi, Joyce F Liu, Ronny Drapkin, Ursula A Matulonis, Dorothy Hallberg, Victor E Velculescu, Joel D Leverson,[...]. Mol Cancer Ther 2019
21

Critical questions in ovarian cancer research and treatment: Report of an American Association for Cancer Research Special Conference.
Robert C Bast, Ursula A Matulonis, Anil K Sood, Ahmed A Ahmed, Adaobi E Amobi, Frances R Balkwill, Monicka Wielgos-Bonvallet, David D L Bowtell, James D Brenton, Joan S Brugge,[...]. Cancer 2019
18